Drug profile · INN
nitazoxanide
ALINIA
nitazoxanide (ALINIA) is a pyruvate:ferredoxin oxidoreductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — nitazoxanide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
nitazoxanide (ALINIA) is a pyruvate:ferredoxin oxidoreductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Pyruvate:ferredoxin oxidoreductase inhibitor
Primary target: Pyruvate dehydrogenase [NADP(+)]
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is nitazoxanide?
nitazoxanide (ALINIA) is a pyruvate:ferredoxin oxidoreductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nitazoxanide?
ALINIA is a marketed brand name for nitazoxanide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nitazoxanide?
nitazoxanide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.